KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Intangibles (2021 - 2025)

Historic Intangibles for Fulgent Genetics (FLGT) over the last 5 years, with Q3 2025 value amounting to $135.3 million.

  • Fulgent Genetics' Intangibles fell 135.65% to $135.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.3 million, marking a year-over-year decrease of 135.65%. This contributed to the annual value of $135.0 million for FY2024, which is 564.48% down from last year.
  • Fulgent Genetics' Intangibles amounted to $135.3 million in Q3 2025, which was down 135.65% from $131.1 million recorded in Q2 2025.
  • Fulgent Genetics' Intangibles' 5-year high stood at $150.6 million during Q4 2022, with a 5-year trough of $6.8 million in Q2 2021.
  • Its 5-year average for Intangibles is $109.8 million, with a median of $135.1 million in 2024.
  • In the last 5 years, Fulgent Genetics' Intangibles surged by 121344.27% in 2022 and then crashed by 569.39% in 2025.
  • Quarter analysis of 5 years shows Fulgent Genetics' Intangibles stood at $35.9 million in 2021, then skyrocketed by 319.45% to $150.6 million in 2022, then fell by 5.04% to $143.1 million in 2023, then decreased by 5.64% to $135.0 million in 2024, then rose by 0.21% to $135.3 million in 2025.
  • Its last three reported values are $135.3 million in Q3 2025, $131.1 million for Q2 2025, and $133.0 million during Q1 2025.